Indivior Pharmaceuticals, Inc. (INDV)
Healthcare
Drug Manufacturers - Specialty & Generic
37.40 $
-6.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Indivior Pharmaceuticals, Inc. (INDV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -9.0 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 | 21 | -280 | -55 | 88 | 8.0 | -5.6 | 75 | 166 | -39 | -221 | -9.0 | -103 | |
| 6.0 | 7.0 | 9.0 | 9.0 | 6.0 | -10 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 4.0 | 19 | |
| 6.0 | 5.0 | 6.0 | 5.0 | 5.0 | 7.0 | 6.0 | 6.0 | 8.0 | 7.0 | 5.0 | 9.0 | 29 | |
| -87 | 211 | -367 | -81 | 190 | -41 | -126 | 18 | 126 | -97 | -302 | -163 | -436 | |
| 1.0 | 2.0 | 3.9 | 2.0 | 4.0 | 9.0 | 16 | 5.0 | 18 | 20 | 24 | 20 | 82 | |
| 22 | -1.5 | 8.2 | 25 | 1.0 | 32 | 9.1 | -5.0 | -19 | -20 | -24 | -19 | -82 | |
| -0.2 | 0.0 | -22 | -36 | -34 | -52 | -49 | -11 | -0.3 | 0.0 | 0.2 | -126 | -126 | |
| – | – | – | – | – | -1.0 | 94 | -4.0 | -4.0 | -4.0 | -5.0 | 156 | 143 | |
| -2.4 | -1.1 | -20 | -38 | -35 | -55 | 29 | -17 | -4.6 | -3.0 | -5.0 | 7.0 | -5.6 | |
| 4.0 | 18 | -294 | -68 | 54 | -14 | 31 | 53 | 138 | -65 | -250 | -20 | -197 | |
| -21 | 19 | -284 | -57 | 84 | -1.0 | -21 | 70 | 148 | -59 | -245 | -29 | -185 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.